These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20688884)

  • 1. Serum phosphate and mortality in patients with chronic kidney disease.
    Eddington H; Hoefield R; Sinha S; Chrysochou C; Lane B; Foley RN; Hegarty J; New J; O'Donoghue DJ; Middleton RJ; Kalra PA
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2251-7. PubMed ID: 20688884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease classification stratifies mortality risk after elective stent graft repair of the thoracic aorta.
    Marrocco-Trischitta MM; Melissano G; Kahlberg A; Calori G; Setacci F; Chiesa R
    J Vasc Surg; 2009 Feb; 49(2):296-301. PubMed ID: 19028056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
    Chiu DY; Kalra PA; Sinha S; Green D
    Nephrology (Carlton); 2016 Jun; 21(6):476-82. PubMed ID: 26426983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization.
    Abramowitz M; Muntner P; Coco M; Southern W; Lotwin I; Hostetter TH; Melamed ML
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1064-71. PubMed ID: 20378645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.
    Chue CD; Edwards NC; Davis LJ; Steeds RP; Townend JN; Ferro CJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2576-82. PubMed ID: 21248296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease.
    Kovesdy CP; Estrada W; Ahmadzadeh S; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):435-41. PubMed ID: 19118116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study.
    Owaki A; Inaguma D; Aoyama I; Inaba S; Koide S; Ito E; Takahashi K; Hayashi H; Hasegawa M; Yuzawa Y;
    Ren Fail; 2018 Nov; 40(1):475-482. PubMed ID: 30153079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid and chronic kidney disease: the Severance cohort study.
    Mok Y; Lee SJ; Kim MS; Cui W; Moon YM; Jee SH
    Nephrol Dial Transplant; 2012 May; 27(5):1831-5. PubMed ID: 21940488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
    Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
    Di Iorio B; Bellasi A; Russo D;
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):487-93. PubMed ID: 22241819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homoarginine, kidney function and cardiovascular mortality risk.
    Tomaschitz A; Meinitzer A; Pilz S; Rus-Machan J; Genser B; Drechsler C; Grammer T; Krane V; Ritz E; Kleber ME; Pieske B; Kraigher-Krainer E; Fahrleitner-Pammer A; Wanner C; Boehm BO; März W
    Nephrol Dial Transplant; 2014 Mar; 29(3):663-71. PubMed ID: 24398889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD.
    Kovesdy CP; Anderson JE; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2009 Apr; 24(4):1232-7. PubMed ID: 19015169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with kidney disease progression and mortality in a referred CKD population.
    Hoefield RA; Kalra PA; Baker P; Lane B; New JP; O'Donoghue DJ; Foley RN; Middleton RJ
    Am J Kidney Dis; 2010 Dec; 56(6):1072-81. PubMed ID: 20692750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.